article thumbnail

If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today

The Motley Fool

But just how well has the stock done over the years, and would it have proven to be a good investment if you bought shares at its initial public offering? 19, 2016 was officially CRISPR Therapeutics' first day of trading. CRISPR Therapeutics is a much safer business now than it was in 2016.

article thumbnail

Arm IPOs on Nvidia's Success and AI Hype. Here's Why I'm Not Touching It

The Motley Fool

It was taken private by Softbank in 2016 at $32 billion, and its last private mark was $64 billion. In this video, I will talk about Arm's initial public offering (IPO) and why I don't think you should buy it on the back of the AI and Nvidia hype. Stock prices used were from the trading day of Aug. 25, 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This Stock Turned $10,000 Into $263,690 Since Its 2016 IPO. Here's Why It's Not Too Late to Buy.

The Motley Fool

One stock that has provided stellar returns for its shareholders since its 2016 initial public offering (IPO) is Kinsale Capital (NYSE: KNSL). Since its IPO in 2016, Kinsale's average annual combined ratio is 81%, meaning it earns $19 in underwriting profit for every $100 in premiums taken in.

article thumbnail

Where Will GoPro Stock Be in 5 Years?

The Motley Fool

With its shares down a stunning 96% since their initial public offering (IPO) in 2014, GoPro (NASDAQ: GPRO) has been a nightmare for early investors. The division closed in 2016. Let's dig deeper to see what the next five years could have in store for this struggling camera company. Both failed spectacularly.

article thumbnail

Bain Capital, Carlyle Group and Cerberus Capital Management Set to Make Bids for Adani Capital

Private Equity Insights

This development comes as Gautam Adani is said to be looking to exit non-core businesses to conserve capital for the core operations Promoters of Adani Capital own nearly 90 per cent of the company, as per a report in The Economic Times, while the rest 10 per cent is owned by investment banker Gaurav Gupta who had joined the group in 2016.

Bidding 236
article thumbnail

Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker

The Motley Fool

The company was formed in 2013, had its initial public offering (IPO) in 2016, and last year, earned approval for Casgevy, a gene-editing treatment for two blood-related disorders: sickle cell disease and transfusion-dependent beta-thalassemia. It's already well on its way.

article thumbnail

The Trade Desk Just Made a Bold Move in Connected TV. Time to Buy?

The Motley Fool

The chart below shows the stock's performance since its 2016 initial public offering. TTD data by YCharts. The Trade Desk has benefited from its exposure to the fast-growing digital advertising industry, but it has also consistently innovated through tools like its cookie-less tracking solution, Unified ID 2.0